Influence of Febrile Neutropenia Period on Plasma Viscosity at Malignancy

Table 2

According to diagnosis used chemotherapy regimens.

Diagnosis	Chemotherapy agents	𝑛
AML	High dose cytarabine 3 gr/sqm q12h iv d1, 3, and 5	17
ALL	Remission induction chemotherapy^2	3
Gastric cancer	5-Fluorouracil 680 mg/d; folinic acid 40 mg/d (iv d1–5)	2
Lung cancer^1	Paclitaxel 250 mg/d; carboplatin 400 mg/d (iv d1)	2
PNET	Carboplatin 400 mg/d (iv d1); etoposide 140 mg/d (iv d1–3)	1
Kaposi's sarcoma	Vinblastine 8 mg/d (iv d1)	2

1Nonsmall cell.
²Cyclophosphamide 1000 mg/sqm/d iv d1, daunorubicin 45 mg/sqm/d iv d1-3, vincristine 2 mg/d iv d1, 8, 15, and 22, prednisolone 60 mg/sqm/d po d1-28, and L-asparaginase 6000 IU/sqm/d iv 6 doses.
AML: acute myeloblastic leukemia; ALL: acute lymphoblastic leukemia; PNET: primitive neuroectodermal tumor.